Status:
COMPLETED
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
Lead Sponsor:
Organon and Co
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
50-79 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.
Eligibility Criteria
Inclusion
- Patients with benign prostatic hyperplasia
Exclusion
- Patients who are suspected to be suffering from prostatic cancer
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2005
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00127179
Start Date
January 1 2004
End Date
July 25 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.